Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone

By Ward Alexandra   Bozkaya Duygu   Fleischmann Jochen   Dubois Dominique   Sabatowski Rainer   Caro J. Jaime  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2333-2345

Informa Healthcare

Access to resources Recommend Favorite

Comparative Effects of Morning vs Evening Dosing of Extended‐Release Hydromorphone on Sleep Physiology in Patients with Low Back Pain: A Pilot Study

By  

PAIN MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 460-471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study

By Gajria Kavita  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Use of extended-release niacin in clinical practice

By Suryadevara Ramya S   Karas Richard H   Kuvin Jeffrey T  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 9-16

Future Medicine

Access to resources Recommend Favorite